ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668254 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668254; 2) Community: the network communities that were significantly associated with the response to NSC 668254; 3) Molecule: the relationships between components within communities and NSC 668254; 4) MDR: the compounds that were significantly associated with the NSC 668254.

NSC Compound Enrichment Correlation
NSC 634784 4-Piperidinone, 1-[3-(dimethylamino)-1-oxopropyl]-3,5- bis(phenylmethylene)-, monohydrochloride 0.00356914129105571 0.48339725
NSC 655105 Cycloshikonin 0.00356914129105571 0.75396364
NSC 657321 1,9-Dioxacyclohexadeca-3,11-diene-2,5,10,13-tetrone, 8,16-bis(2-oxopropyl)-, [8S-(3E,8R*,11E,16R*)]- 0.00356914129105571 0.71377828
NSC 665335 Null 0.00356914129105571 0.27649786
NSC 683564 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, methyl ester, (Z,E)- 0.00356914129105573 0.73940021
NSC 676368 5-Pyrimidinecarboxaldehyde, 2-amino-4-chloro- 6-[[[1-(hydroxymethyl)-3-(1-methylethyl)- 1-cyclobutyl]methyl]amino]- 0.00356914129105574 0.25484565
NSC 706010 Null 0.00356914129105574 -0.074454821
NSC 708441 3-Iodoacetamido-benzoylurea 0.00356914129105574 0.53936073
NSC 724615 thiopyrimidine-CH3 0.00356914129105574 0.26182014
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.00356914129105574 0.080609169
Total:121  Current:12    [First] [Prev] [Next] [Last]